About Noble Life Sciences
Noble Life Sciences is a company based in Woodbine (United States) founded in 2010.. Noble Life Sciences has raised $335 thousand across 2 funding rounds from investors including TEDCO. Noble Life Sciences offers products and services including Preclinical Testing, Bioanalysis, Flow Cytometry, and Toxicology Services. Noble Life Sciences operates in a competitive market with competitors including TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.
- Headquarter Woodbine, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$335 K (USD)
in 2 rounds
-
Latest Funding Round
$100 K (USD), Seed
Jun 01, 2013
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Noble Life Sciences
Noble Life Sciences offers a comprehensive portfolio of products and services, including Preclinical Testing, Bioanalysis, Flow Cytometry, and Toxicology Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Conducts safety and efficacy tests for drugs and devices.
Performs testing for pharmacodynamic modeling in drug development.
Analyzes immune cells in preclinical oncology studies.
Evaluates toxicity in animal models for therapeutic development.
Unlock access to complete
Unlock access to complete
Funding Insights of Noble Life Sciences
Noble Life Sciences has successfully raised a total of $335K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $100 thousand completed in June 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $100,000
-
First Round
First Round
(30 Mar 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2013 | Amount | Seed - Noble Life Sciences | Valuation |
investors |
|
| Mar, 2012 | Amount | Seed - Noble Life Sciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Noble Life Sciences
Noble Life Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include TEDCO. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund and startup accelerator programs focused on seed and early stage companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Noble Life Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Noble Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Noble Life Sciences Comparisons
Competitors of Noble Life Sciences
Noble Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Humanized mouse models are developed for preclinical immune drug studies.
|
|
| domain | founded_year | HQ Location |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| domain | founded_year | HQ Location |
Preclinical CRO services for CNS and orphan disorders are offered.
|
|
| domain | founded_year | HQ Location |
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
|
|
| domain | founded_year | HQ Location |
Animal models are supplied for in-vivo analytical services.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Noble Life Sciences
Frequently Asked Questions about Noble Life Sciences
When was Noble Life Sciences founded?
Noble Life Sciences was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Where is Noble Life Sciences located?
Noble Life Sciences is headquartered in Woodbine, United States. It is registered at Woodbine, New Jersey, United States.
Is Noble Life Sciences a funded company?
Noble Life Sciences is a funded company, having raised a total of $335K across 2 funding rounds to date. The company's 1st funding round was a Seed of $235K, raised on Mar 30, 2012.
What does Noble Life Sciences do?
Noble Life Sciences is a preclinical contract research organisation offering standard GLP and non-GLP services, including safety and efficacy testing, for the development of drugs, vaccines, and medical devices. They offer preclinical testing in a wide variety of mammalian species including rabbits, rats, mice, ferrets, guinea pigs, sheep, goats, domestic swine and mini pigs. Their services also include the derivation and maintenance of animal breeding colonies, animal housing and husbandry, the production of custom antibodies, and the development of disease and animal models. The company offers specialised services for oncology drug evaluation, polyclonal antibody production and vaccine development.
Who are the top competitors of Noble Life Sciences?
Noble Life Sciences's top competitors include GenOway, PsychoGenics and Alpha Genesis.
What products or services does Noble Life Sciences offer?
Noble Life Sciences offers Preclinical Testing, Bioanalysis, Flow Cytometry, and Toxicology Services.
Who are Noble Life Sciences's investors?
Noble Life Sciences has 1 investor. Key investors include TEDCO.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.